Technical University of Munich   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Munich Germany (1868)

Organization Overview

First Clinical Trial
1993
NCT01317108
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinic director - Department of anesthesiology and intensive care | Department of Anesthesiology, German Heart Center Munich | Department of Neurology, Klinikum rechts der Isar, Technical University of Munich | Department of Neurology, Motala Hospital, Motala, Sweden | Department of Neurology, TU Munich | Department of Nuclear Medicine, University of Munich | Department of Urology, Klinikum rechts der Isar der Technischen Universität München | Dept. of Psychiatry, Technical University of Munich | Deutsches Herzzentrum München | Deutsches Herzzentrum Muenchen | Deutsches Herzzentrum München | Deutsches Herzzentrum Munich Germany | Deutsches Herzzentum München | Diabetes Research Institute, Munich, Germany. | Dominik Irnich | German Heart Institute Munich | German Heart Institute Munich, Competence Network for Congenital Heart Defects | Head of the gastroenterological department of the Klinikum rechts der Isar | Heart Center Munich at the Isar | Heart Center Munich at the Isar, Munich, Germany | III.Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der TUM | II. Medizinische Klinik, Klinikum rechts der Isar (MRI) der TUM,Ismaninger Str. 22 | IMSE, TU Munich (Biometry) | INETUM | Institute of Medical Informatics, Statistics and Epidemiology, TU Munich | Institut fur Diabetesforschung, Munich, Germany | Isotope Technologies Munich (ITM) Oncologics | Klinikum rechts der Isar | Klinikum rechts der Isar der Technischen Universitaet Muenchen | Klinikum rechts der Isar der TUM | Klinikum rechts der Isar, Technical University Munich, Dept. of Anesthesiology | Klinikum rechts der Isar, TUM, Department Nephrology | Klinikum rechts der Isar, TUM Institute for AI and Informatics in Medicine (AIIM) | Klinikum re. Isar, Technische Universität München, Dermatologie | Medical faculty of the Technical University Munich | Munich Academic Teaching Hospital Bogenhausen | Munich Technische Universität (TUM) | National Center for Tumor Diseases (NCT) | National Center for Tumor Diseases (NCT) | Heidelberg University Hospital and German Cancer Research Center | National Center for Tumor Diseases, University Hospital Heidelberg | Nationales Centrum für Tumorerkrankungen | Pneumologie Elisenhof Munich | School of Medicine, Technical University Munich, Münchner Studienzentrum | Stephanie Combs | Technical University Munich | Technical University, Munich | Technical University of Munich | Technical University of Munich, 2nd Medical Department | Technischen Universitat Munchen | Technische Universität München | Technische Universität München, Klinikum rechts der Isar, Klinik und Poliklinik für Neurologie | Technische Universität München, Klinik und Poliklinik für Neurochirurgie | TUM | University Hospital Klinikum rechts der Isar, Technische Universitaet Muenchen | University Hospital Munich, Germany

Active Ingredients

Drugs in Phase 4 Trials (54)

abciximab (Reopro) (3 trials)

acetylcysteine (mucomyst) (1 trial)

acetylsalicylic acid (aspirin) (2 trials)

albumin (Human) (Plasbumin) (1 trial)

amisulpride (BARHEMSYS) (3 trials)

Benperidol (glianimon) (1 trial)

bivalirudin (angiomax) (3 trials)

bromperidol (tesoprel) (1 trial)

cefuroxime (zinacef) (1 trial)

clopidogrel (plavix) (5 trials)

clozapine (clozaril) (1 trial)

dabigatran (pradaxa) (2 trials)

donepezil (aricept) (1 trial)

everolimus (zortress) (3 trials)

flupentixol (Depixol) (1 trial)

fluphenazine (permitil) (1 trial)

fluspirilene (1 trial)

gabapentin (neurontin) (1 trial)

galantamine (reminyl) (1 trial)

haloperidol (haldol) (1 trial)

heparin (liquaemin) (5 trials)

insulin detemir (Levemir) (1 trial)

insulin human (humulin) (6 trials)

insulin lispro (humalog) (1 trial)

iodixanol (visipaque) (1 trial)

Iomeprol (1 trial)

ketamine (ketalar) (1 trial)

memantine (namenda) (1 trial)

neostigmine (bloxiverz) (1 trial)

olanzapine (zyprexa) (4 trials)

paclitaxel (taxol) (6 trials)

paliperidone (invega) (1 trial)

perphenazine (trilafon) (1 trial)

phenprocoumon (liquamar) (2 trials)

pimozide (orap) (1 trial)

prasugrel (effient) (3 trials)

prilocaine (citanest) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

propofol (diprivan) (6 trials)

quetiapine (seroquel) (2 trials)

remifentanil (ultiva) (3 trials)

ribociclib (kisqali) (1 trial)

risperidone (risperdal) (1 trial)

sargramostim (leukine) (2 trials)

sertindole (Serdolect) (1 trial)

sevoflurane (ultane) (3 trials)

sirolimus (rapamune) (1 trial)

sugammadex (bridion) (2 trials)

sulpiride (1 trial)

theophylline (synophylate) (2 trials)

thioridazine (mellaril) (1 trial)

ticagrelor (brilinta) (3 trials)

ziprasidone (geodon) (1 trial)

zuclopenthixol (1 trial)

Drugs in Phase 3 Trials (26)

abacavir (ziagen) (1 trial)

aprotinin (trasylol) (1 trial)

capecitabine (xeloda) (4 trials)

cisplatin (platinol) (3 trials)

clemastine (TAVIST) (2 trials)

darunavir (prezista) (2 trials)

dolutegravir (tivicay) (1 trial)

epoetin (Epogen) (1 trial)

fluorouracil (efudex) (6 trials)

gemcitabine (gemzar) (5 trials)

irinotecan (Camptosar) (2 trials)

letrozole (femara) (1 trial)

leucovorin (4 trials)

mirtazapine (remeron) (1 trial)

mycophenolate (CellCept) (1 trial)

oxaliplatin (eloxatin) (6 trials)

pazopanib (votrient) (1 trial)

prednisolone (hydeltra) (1 trial)

ritonavir (Norvir) (3 trials)

secretin human (chirhostim) (1 trial)

sildenafil (viagra) (1 trial)

sorafenib (nexavar) (1 trial)

temsirolimus (torisel) (2 trials)

tenofovir (viread) (2 trials)

tranexamic acid (cyklokapron) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 2 Trials (52)

alemtuzumab (campath) (1 trial)

anastrozole (arimidex) (1 trial)

apremilast (otezla) (1 trial)

atezolizumab (Tecentriq) (1 trial)

autologous natural killer cells (1 trial)

beta-glucans (2 trials)

bevacizumab (avastin) (1 trial)

bevacizumab-irdye800cw (1 trial)

calcitriol (rocaltrol) (1 trial)

cannabidiol (Epidiolex) (1 trial)

carboplatin (paraplatin) (3 trials)

cetuximab (erbitux) (2 trials)

cortisone acetate (cortone) (1 trial)

cyclophosphamide (cytoxan) (3 trials)

cytarabine (cytosar-u) (1 trial)

docetaxel (taxotere) (1 trial)

dupilumab (dupixent) (1 trial)

epirubicin (ellence) (2 trials)

fasudil (1 trial)

fbta05 (1 trial)

fludarabine (fludara) (1 trial)

fluorescein (1 trial)

gadobutrol (gadavist) (1 trial)

gantacurium (1 trial)

gdc-0077 (1 trial)

glycerol phenylbutyrate (ravicti) (1 trial)

goserelin (zoladex) (1 trial)

ibritumomab tiuxetan (Zevalin) (1 trial)

icatibant (firazyr) (1 trial)

imatinib (gleevec) (2 trials)

ipatasertib (1 trial)

lamotrigine (lamictal) (1 trial)

lovastatin (mevacor) (1 trial)

modafinil (provigil) (1 trial)

nilotinib (tasigna) (1 trial)

nivolumab (opdivo) (1 trial)

olaparib (lynparza) (2 trials)

omalizumab (xolair) (1 trial)

panobinostat (farydak) (1 trial)

pembrolizumab (keytruda) (2 trials)

pertuzumab (perjeta) (1 trial)

prednisone (meticorten) (1 trial)

prs-080 (2 trials)

ramucirumab (cyramza) (1 trial)

revacept (2 trials)

rituximab (rituxan) (3 trials)

sacituzumab govitecan (Trodelvy) (1 trial)

secukinumab (cosentyx) (1 trial)

tamoxifen (nolvadex) (1 trial)

trastuzumab (herceptin) (2 trials)

urea (1 trial)

vildagliptin (1 trial)

Drugs in Phase 1 Trials (11)

[18f]pi-2620 (1 trial)

afatinib (gilotrif) (1 trial)

cobicistat (stribild) (1 trial)

elvitegravir (vitekta) (1 trial)

emtricitabine (emtriva) (2 trials)

her2-peptid-vakzine (1 trial)

imiquimod (aldara) (1 trial)

lopinavir (Kaletra) (1 trial)

lu-177 labeled 6a10-fab-fragments (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

wobenzyme (1 trial)

Drugs in Other Trials (9)

bifidobacterium infantis (1 trial)

icosapent ethyl (vascepa) (1 trial)

l-epigallocatechin (1 trial)

rocuronium (zemuron) (1 trial)

sinigrin (1 trial)

sodium bicarbonate (1 trial)

sodium chloride (2 trials)

testosterone (delatestryl) (1 trial)

umami (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Alzheimer Disease (Phase 4)

Amaurosis Fugax (Phase 2)

Angina Pectoris (Phase 4)

Angina, Stable (Phase 3)

Angina, Unstable (Phase 4)

Angioedema (Phase 3)

Arteriosclerosis (Phase 4)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 4)

Blindness (Phase 2)

Blood Coagulation Disorders (Phase 1)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 2)

Cardiovascular Diseases (Phase 1)

Carotid Stenosis (Phase 2)

Cholangiocarcinoma (Phase 2)

Cognitive Dysfunction (Phase 2)

Constriction, Pathologic (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronary Restenosis (Phase 4)

Death (Phase 1)

Death, Sudden (Phase 1)

Death, Sudden, Cardiac (Phase 1)

Depression (Phase 3)

Depressive Disorder, Major (Phase 3)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Diabetes, Gestational (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 4)

Disease (Phase 4)

Eczema (Phase 2)

Eisenmenger Complex (Phase 3)

Esophageal Neoplasms (Phase 2)

Familial Primary Pulmonary Hypertension (Phase 3)

Gastrointestinal Stromal Tumors (Phase 2)

Heart Diseases (Phase 4)

Hemorrhage (Phase 3)

Hemostatic Disorders (Phase 1)

Herpes Zoster (Phase 4)

HIV Infections (Phase 3)

Hypertension (Phase 3)

Hypoalbuminemia (Phase 4)

Infarction (Phase 4)

Inflammation (Phase 1)

Insulin Resistance (Phase 1)

Ischemic Attack, Transient (Phase 2)

Kidney Diseases (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Neuralgia (Phase 4)

Neuralgia, Postherpetic (Phase 4)

Pancreatic Neoplasms (Phase 3)

Pathologic Processes (Phase 1)

Psychotic Disorders (Phase 4)

Pyoderma (Phase 2)

Pyoderma Gangrenosum (Phase 2)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Tract Infections (Phase 1)

Schizophrenia (Phase 4)

Schizophrenia Spectrum and Other Psychotic Disorders (Phase 4)

Sleep Deprivation (Phase 2)

Stomach Neoplasms (Phase 3)

Syndrome (Phase 4)

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 116
  • # of Trial APIs: 152